BioSpace News Archive

Sanofi Reports Strong Second Quarter Driven by Dupixent Launch and Vaccine Sales

Sanofi reported overall net sales increased by 5.5% for the second quarter, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.

July 29, 2019
·
2 min read
·
Mark Terry
Genetown

Tunable CAR-T Therapies: A New Generation of Small, Molecule-Controlled Therapies

What if you could more precisely control CAR-T cells using FDA-approved small molecules to enhance their activity against solid tumors? That’s exactly what Obsidian Therapeutics is aiming to do.

July 29, 2019
·
7 min read
·
Chelsea Weidman Burke
Business

Biotech Youth Training Program to be Offered in India

The Tribune India has recently announced that the Department of Biotechnology will be training “unemployed youth in tools and techniques in the area of biotechnology within a period of three years.”

July 29, 2019
·
4 min read
·
Elizabeth Glasure
Deals

Quanta Raises $48 million in Series C Funding Round

Funds will support UK commercial launch and FDA 510(k) submission later this year

July 29, 2019
·
3 min read
Business

Silence Therapeutics appoints Dr. Steven Romano as a Non-Executive Director

Silence Therapeutics, PLC is pleased to announce that further to the announcements on 18 July 2019 detailing the Company’s collaboration with and equity investment by Mallinckrodt plc, Steven Romano, MD, has joined the Board of Silence as a Non-Executive Director.

July 29, 2019
·
3 min read
Drug Development

GeoVax Announces 100% Protection Data from Marburg Virus Vaccine Study

Study Data Adds to Similar Efficacy Previously Reported for GeoVax’s Ebola and Lassa Fever Vaccines

July 29, 2019
·
4 min read
Deals

Mylan’s Merger with Pfizer’s Off-Patent Drug Unit Will Create ‘New Champion for Global Health’

The new company will be helmed by Mylan’s Michael Goettler and is expected to generate 2020 revenues of $19 to $20 billion.

July 29, 2019
·
3 min read
·
Alex Keown
Rare Skin Lymphoma Appears Treatable with Antibiotics

Researchers with the LEO Foundation Skin Immunology Research Center at the Faculty of Health and Medical Sciences, the University of Copenhagen, showed that aggressive antibiotic treatment could not only inhibit the staph infection, but also the cancer cells.

July 29, 2019
·
2 min read
·
Mark Terry
Business

Vertex Appoints First Female CEO

Taking over the reins of the company will be Vertex’s Chief Medical Officer Reshma Kewalramani. She will assume the role of president and CEO and also take a seat on the board of directors, Vertex announced.

July 29, 2019
·
3 min read
·
Alex Keown
Deals

Exact Sciences and Genomic Health Merge to Form Leading Cancer Diagnostics Company

The combined companies will have revenue drivers of two commercially available diagnostics tools, Cologuard and Oncotype DX.

July 29, 2019
·
3 min read
·
Alex Keown